As of May 2, 2025, Captor Capital Corp.'s market capitalization has reached $1.38 M. According to our data, Captor Capital Corp. is the 46220th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap
1.38 M
Revenue (ttm)
7.19 M
Net Income (ttm)
15.43 M
Shares Out
3.47 M
EPS (ttm)
4.44
Forward PE
0.00
Ex-Dividend Date
n/a
Earnings Date
July 28, 2025
Market Cap Chart
Data Updated: May 2, 2025
Captor Capital Corp.'s yearly market capitalization.
Captor Capital Corp. has seen its market value drop from C$10.04 M to C$2.08 M since 2020, representing a total decrease of 79.25% and an annual compound decline rate (CAGR) of 30.67%.
Date
Market Cap
Change (%)
April 17, 2025
C$2.08 M
-13.04%
December 18, 2024
C$2.40 M
-51.57%
December 28, 2023
C$4.95 M
-76.27%
July 11, 2022
C$20.86 M
-57.65%
December 31, 2021
C$49.24 M
390.23%
December 31, 2020
C$10.04 M
Company Profile
About Captor Capital Corp.
Captor Capital Corp. is a cannabis retail company operating in the United States, specializing in the sale of cannabis products.
Company Background
Formerly Known As: NWT Uranium Corp.
Name Change: Renamed to Captor Capital Corp. on June 2, 2017.
Founded: 2003
Headquarters: Toronto, Canada
Frequently Asked Questions
As of May 2, 2025, Captor Capital Corp. (including the parent company, if applicable) has an estimated market capitalization of $1.38 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Captor Capital Corp. global market capitalization ranking is approximately 46220 as of May 2, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.
Stock Detail
Country or region
Canada
Founded
2003
IPO Date
n/a
Employees
105
CEO
John Zorbas
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
4 King Street West Toronto, Ontario M5H 1B6 Canada